ClinicalTrials.gg
Drug

Sacubitril valsartan clinical trials

Includes 88 studies of Sacubitril valsartan sodium hydrate.

studies test it
91
open now
7
in phase 3
24
first study started
2007

How each study uses sacubitril valsartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sacubitril valsartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Jul 2015 · ENTRESTO · NDA 207620 (FDA, Drugs@FDA; as sacubitril valsartan sodium hydrate)
European Union
19 Nov 2015 · Entresto · EMEA/H/C/004062 (EMA; as sacubitril valsartan sodium hydrate)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)
2

Studies by the year they started

91 studies that test it; most in 2016 (13)

Studies that test sacubitril valsartan, by start year
YearStudies
20071
20094
20102
20112
201210
20134
20143
20152
201613
20174
20187
201910
20209
20217
20225
20232
20243
20252
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
4
Phase 2
30
Phase 3
24
Phase 4
30
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 41 · Other 50

Novartis Pharmaceuticals (41) · Vanderbilt University Medical Center (3) · Brigham and Women's Hospital (2) · Mayo Clinic (2) · Duke University (2) · The Cleveland Clinic (2) · Ohio State University (1) · Saga University (1)

Often tested with

Tested in the same studies.

Valsartan (7) · Enalapril (3) · Sitagliptin (2) · Sacubitril (2) · Sertraline (1) · Clonazepam (1) · Alprazolam (1) · Metoprolol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test sacubitril valsartan, phase 3 first.

Studies

Open first, then newest update. How each study uses sacubitril valsartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 91

See all 91 studies that test sacubitril valsartan →

Given beside what is tested · 7 — sacubitril valsartan is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with sacubitril valsartan

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call sacubitril valsartan · ClinicalTrials.gg INT015221

  • UNII (FDA) 688RNR55GHSACUBITRIL VALSARTANOne source FDA
  • NCI Thesaurus C222078Sacubitril ValsartanOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.